Improving Drug Delivery for Hearing Loss Treatments
Minipig Model Validation for Hearing Research and Drug and Device Development
This project aims to create a better animal model to help develop new medicines and devices for people with hearing loss.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Turner Scientific, LLC NIH-funded |
| Lab location | 1 site (Jacksonville, United States) |
| Project ID | NIH-11145919 on NIH RePORTER |
What this research studies
Many past efforts to deliver medicines directly to the inner ear for hearing loss have not worked well in human trials, leading to setbacks in the field. Researchers believe this is because the drugs don't always reach the right places in the ear or spread effectively. This project will use minipigs to create a more accurate model for testing new treatments, as their inner ear anatomy is more similar to humans than smaller animals. By understanding how drugs move through the minipig ear, scientists hope to design more effective therapies for people.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but it is relevant to individuals experiencing acquired deafness or hearing loss who may benefit from future drug or device therapies.
Not a fit: Patients seeking immediate treatment or direct participation in a clinical trial would not find a direct benefit from this specific animal model validation project.
Why it matters
Potential benefit: If successful, this work could lead to more effective drug and device treatments for various types of hearing loss by improving how new therapies are tested before reaching human trials.
How similar studies have performed: Past drug delivery efforts for hearing loss have faced challenges in clinical trials, highlighting the need for more reliable preclinical models like the one proposed here.
Where this research is happening
Jacksonville, United States
- Turner Scientific, LLC — Jacksonville, United States (Active)
Researchers
- Principal investigator: Turner, Jeremy G — Turner Scientific, LLC
- Study coordinator: Turner, Jeremy G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.